chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills After First Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills After First Vaccine) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced CHILLS (Chills After First Vaccine). In March 2021, CHILLS (Chills After First Vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-085551 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up information on received on 24 May 2021 and does not contain any new information.
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Possibly did not get full second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Possibly did not get full second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Possibly did not get full second dose). At the time of the report, ACCIDENTAL UNDERDOSE (Possibly did not get full second dose) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Did not receive 2nd vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027-A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not receive 2nd vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: she is not sure if she got the full dose or not; She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (she is not sure if she got the full dose or not) and DEVICE CONNECTION ISSUE (She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001L21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced UNDERDOSE (she is not sure if she got the full dose or not) and DEVICE CONNECTION ISSUE (She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose). On 22-Apr-2021, UNDERDOSE (she is not sure if she got the full dose or not) and DEVICE CONNECTION ISSUE (She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Headache, Heart rate increased, Nausea, Palpitations
Clinical narrative: pressure mainly at her right ear; hives; mild heart pounding; fast heartbeat; nausea; pressure headache: 6/10; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (pressure mainly at her right ear), URTICARIA (hives), PALPITATIONS (mild heart pounding), HEART RATE INCREASED (fast heartbeat) and NAUSEA (nausea) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pressure mainly at her right ear), URTICARIA (hives), PALPITATIONS (mild heart pounding), HEART RATE INCREASED (fast heartbeat), NAUSEA (nausea) and HEADACHE (pressure headache: 6/10). At the time of the report, EAR PAIN (pressure mainly at her right ear), URTICARIA (hives), PALPITATIONS (mild heart pounding), HEART RATE INCREASED (fast heartbeat), NAUSEA (nausea) and HEADACHE (pressure headache: 6/10) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: pressure mainly at her right ear; hives; mild heart pounding; fast heartbeat; nausea; pressure headache: 6/10; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (pressure mainly at her right ear), URTICARIA (hives), PALPITATIONS (mild heart pounding), HEART RATE INCREASED (fast heartbeat) and NAUSEA (nausea) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pressure mainly at her right ear), URTICARIA (hives), PALPITATIONS (mild heart pounding), HEART RATE INCREASED (fast heartbeat), NAUSEA (nausea) and HEADACHE (pressure headache: 6/10). At the time of the report, EAR PAIN (pressure mainly at her right ear), URTICARIA (hives), PALPITATIONS (mild heart pounding), HEART RATE INCREASED (fast heartbeat), NAUSEA (nausea) and HEADACHE (pressure headache: 6/10) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Hypersomnia
Clinical narrative: sleeps 8-10 hours a day; weakness; tiredness \ fatigue during the day; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (sleeps 8-10 hours a day), ASTHENIA (weakness) and FATIGUE (tiredness \ fatigue during the day) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included APIXABAN (ELIQUIS), CARVEDILOL and INSULIN for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 21-Feb-2021, the patient experienced HYPERSOMNIA (sleeps 8-10 hours a day), ASTHENIA (weakness) and FATIGUE (tiredness \ fatigue during the day). At the time of the report, HYPERSOMNIA (sleeps 8-10 hours a day), ASTHENIA (weakness) and FATIGUE (tiredness \ fatigue during the day) outcome was unknown.            no treatment and concomitant medications reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: When she lifts her arm it hurts to move; Left arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (When she lifts her arm it hurts to move) and MYALGIA (Left arm was sore) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (When she lifts her arm it hurts to move) and MYALGIA (Left arm was sore). At the time of the report, PAIN IN EXTREMITY (When she lifts her arm it hurts to move) and MYALGIA (Left arm was sore) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication was reported.  Treatment medication was not provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: little bit congestion; tested positive for covid-19; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Apr-2021 and was forwarded to Moderna on 22-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and NASAL CONGESTION (little bit congestion) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for covid-19). On an unknown date, the patient experienced NASAL CONGESTION (little bit congestion). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and NASAL CONGESTION (little bit congestion) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, SARS-CoV-2 test: positive On APR 3, the patient received the result of covid-19 PCR test, which was positive. and negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient got her first shot 8 weeks ago) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient got her first shot 8 weeks ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient got her first shot 8 weeks ago) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. No treatment was provided. Reporter did not allow further contact.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive for Covid-19; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 positive test in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced COVID-19 (Tested positive). At the time of the report, COVID-19 (Tested positive) outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Symptoms started to appear on the 6th of April. Reporter wasn't sure of concomitant medications and treatment information.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: Fever 100.4 F; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 100.4 F) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced PYREXIA (Fever 100.4 F) and HEADACHE (headache). At the time of the report, PYREXIA (Fever 100.4 F) and HEADACHE (headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Body temperature: 100.4 f (High) Body temperature increased.         Concomitant medication was not provided. Treatment information was not provided. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  in response to the events were not applicable.   This case was linked to MOD-2021-085521 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: TCR doc is added on 24-MAY-2021 where no new information.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Pain in extremity, Tinnitus
Clinical narrative: feeling sick; sore arm; a lot of headaches; dull ringing in the ear; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling sick), PAIN IN EXTREMITY (sore arm), HEADACHE (a lot of headaches) and TINNITUS (dull ringing in the ear) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 13B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced MALAISE (feeling sick), PAIN IN EXTREMITY (sore arm), HEADACHE (a lot of headaches) and TINNITUS (dull ringing in the ear). At the time of the report, MALAISE (feeling sick), PAIN IN EXTREMITY (sore arm), HEADACHE (a lot of headaches) and TINNITUS (dull ringing in the ear) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: feeling woozy; Chills; Farigue; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feeling woozy), CHILLS (Chills), FATIGUE (Farigue), NAUSEA (Nausea) and HEADACHE (Headache) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced DIZZINESS (feeling woozy), CHILLS (Chills), FATIGUE (Farigue), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, DIZZINESS (feeling woozy), CHILLS (Chills), FATIGUE (Farigue), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment information was not reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Erythema, Headache, Rhinorrhoea
Clinical narrative: pain and hardness at the injection; itchy inflamed lump at injection site.; red; Runny nose; coughing; pain in the knee, feet and nails; headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red), VACCINATION SITE MASS (itchy inflamed lump at injection site.), COUGH (coughing), RHINORRHOEA (Runny nose) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red), VACCINATION SITE MASS (itchy inflamed lump at injection site.), COUGH (coughing), RHINORRHOEA (Runny nose), HEADACHE (headache), ARTHRALGIA (pain in the knee, feet and nails) and VACCINATION SITE PAIN (pain and hardness at the injection). At the time of the report, ERYTHEMA (red), COUGH (coughing), RHINORRHOEA (Runny nose), HEADACHE (headache) and ARTHRALGIA (pain in the knee, feet and nails) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pain
Clinical narrative: pain and hardness at the injection; itchy inflamed lump at injection site.; red; Runny nose; coughing; pain in the knee, feet and nails; headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red), VACCINATION SITE MASS (itchy inflamed lump at injection site.), COUGH (coughing), RHINORRHOEA (Runny nose) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red), VACCINATION SITE MASS (itchy inflamed lump at injection site.), COUGH (coughing), RHINORRHOEA (Runny nose), HEADACHE (headache), ARTHRALGIA (pain in the knee, feet and nails) and VACCINATION SITE PAIN (pain and hardness at the injection). At the time of the report, ERYTHEMA (red), COUGH (coughing), RHINORRHOEA (Runny nose), HEADACHE (headache) and ARTHRALGIA (pain in the knee, feet and nails) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash
Clinical narrative: Pain in arm after first dose; redness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm after first dose), ERYTHEMA (redness) and RASH (Rash) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm after first dose), ERYTHEMA (redness) and RASH (Rash). At the time of the report, PAIN IN EXTREMITY (Pain in arm after first dose), ERYTHEMA (redness) and RASH (Rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided No concomitant medications were reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fibromyalgia, Pain, Pain in extremity
Clinical narrative: My arm is sore; fibromyalgia; It hurts from my left hip down to my left knee; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My arm is sore), FIBROMYALGIA (fibromyalgia) and PAIN (It hurts from my left hip down to my left knee) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (My arm is sore), FIBROMYALGIA (fibromyalgia) and PAIN (It hurts from my left hip down to my left knee). At the time of the report, PAIN IN EXTREMITY (My arm is sore), FIBROMYALGIA (fibromyalgia) and PAIN (It hurts from my left hip down to my left knee) outcome was unknown. Not Provided          No concomitant medication was reported. Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26-MAY-2021. No newinformation
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Myalgia, Nausea
Clinical narrative: warm feeling all over; Fatigue; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea). At the time of the report, FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea) outcome was unknown.            No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pruritus, Skin warm, Vaccination site erythema
Clinical narrative: her arm was itching; arm is swollen and warm; her arm is warm; the injection site was red the redness progressed down her arm 4 inches long; her arm a little sore; her arm warm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her arm a little sore), SKIN WARM (her arm warm), PRURITUS (her arm was itching), PERIPHERAL SWELLING (arm is swollen and warm) and SKIN WARM (her arm is warm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not reported.  Concomitant products included SPIRONOLACTONE, FUROSEMIDE and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (her arm a little sore) and SKIN WARM (her arm warm). On 21-Apr-2021, the patient experienced PRURITUS (her arm was itching), PERIPHERAL SWELLING (arm is swollen and warm), SKIN WARM (her arm is warm) and VACCINATION SITE ERYTHEMA (the injection site was red the redness progressed down her arm 4 inches long). On 14-Apr-2021, PAIN IN EXTREMITY (her arm a little sore) had resolved, SKIN WARM (her arm warm) had resolved with sequelae. At the time of the report, PRURITUS (her arm was itching), PERIPHERAL SWELLING (arm is swollen and warm), SKIN WARM (her arm is warm) and VACCINATION SITE ERYTHEMA (the injection site was red the redness progressed down her arm 4 inches long) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Eye drop for glaucoma. Treatment included Cortisone cream.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, SARS-CoV-2 test positive
Clinical narrative: It is been more than 35 days and did not get second dose; Covid-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It is been more than 35 days and did not get second dose) and SARS-COV-2 TEST POSITIVE (Covid-19 virus test positive) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid-19 virus test positive). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It is been more than 35 days and did not get second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It is been more than 35 days and did not get second dose) and SARS-COV-2 TEST POSITIVE (Covid-19 virus test positive) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Product dose omission issue
Clinical narrative: 17 year-old received 1st dose Moderna COVID-19 vaccine; denied to give 2nd dose since patient is 17 years old; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old received 1st dose Moderna COVID-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (denied to give 2nd dose since patient is 17 years old) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old received 1st dose Moderna COVID-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (denied to give 2nd dose since patient is 17 years old). On 25-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old received 1st dose Moderna COVID-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (denied to give 2nd dose since patient is 17 years old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment medications were provided
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Emotional disorder
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of AGITATION (feeling agitated) and EMOTIONAL DISORDER (very emotional) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 045A21A) for COVID-19 vaccination. No medical history was provided by the reporter.  On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced AGITATION (feeling agitated). On 21-Apr-2021, the patient experienced EMOTIONAL DISORDER (very emotional). At the time of the report, AGITATION (feeling agitated) and EMOTIONAL DISORDER (very emotional) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Fatigue, Musculoskeletal stiffness, Myalgia, Pain
Clinical narrative: pain on both quadriceps; leg pain/ pain in arm; muscle on fire; tenderness at vaccination site; burning sensation; stiffness in his R quadricep; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation), MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep), PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm) and MYALGIA (muscle on fire) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) for an unknown indication.    On 21-Apr-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced FATIGUE (fatigue). On 22-Apr-2021, the patient experienced BURNING SENSATION (burning sensation) and MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep). On an unknown date, the patient experienced PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm), MYALGIA (muscle on fire) and VACCINATION SITE PAIN (tenderness at vaccination site). At the time of the report, BURNING SENSATION (burning sensation), MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep), PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm), MYALGIA (muscle on fire), VACCINATION SITE PAIN (tenderness at vaccination site) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details  included occasionally nausea medications. Event outcome details were not reported. Patient wants to know whether these side effects normal? and what should he do for the muscle aches?
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: pain on both quadriceps; leg pain/ pain in arm; muscle on fire; tenderness at vaccination site; burning sensation; stiffness in his R quadricep; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation), MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep), PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm) and MYALGIA (muscle on fire) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) for an unknown indication.    On 21-Apr-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced FATIGUE (fatigue). On 22-Apr-2021, the patient experienced BURNING SENSATION (burning sensation) and MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep). On an unknown date, the patient experienced PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm), MYALGIA (muscle on fire) and VACCINATION SITE PAIN (tenderness at vaccination site). At the time of the report, BURNING SENSATION (burning sensation), MUSCULOSKELETAL STIFFNESS (stiffness in his R quadricep), PAIN (pain on both quadriceps), PAIN IN EXTREMITY (leg pain/ pain in arm), MYALGIA (muscle on fire), VACCINATION SITE PAIN (tenderness at vaccination site) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details  included occasionally nausea medications. Event outcome details were not reported. Patient wants to know whether these side effects normal? and what should he do for the muscle aches?
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blood test, Computerised tomogram, Dizziness, Dyspnoea
Clinical narrative: tingling in her throat; "funny sensation" in throat; woozy; pain in back; pain in lung when breathing; pain in lung when breathing; body inflammation on CAT scan; sore arm/body ache; headache; Her arm was also sore at the site of the injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back) and PULMONARY PAIN (pain in lung when breathing) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included NORETHINDRONE ACETATE, MULTI VITAMINS & MINERALS and PRO BIOTIC BLEND for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Inflammation, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Inflammation, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Inflammation, at an unspecified dose and frequency. At the time of the report, PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: elevated (High) Test for blood clot was elevated. On an unknown date, Computerised tomogram: inflammation (abnormal) Inflammation all over the body.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On an unknown date, prior to mRNA-1273, antibody test was positive.   This case was linked to US-MODERNATX, INC.-MOD-2021-085271 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085271:Case for husband
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inflammation, Myalgia, Oropharyngeal discomfort, Pharyngeal paraesthesia
Clinical narrative: tingling in her throat; "funny sensation" in throat; woozy; pain in back; pain in lung when breathing; pain in lung when breathing; body inflammation on CAT scan; sore arm/body ache; headache; Her arm was also sore at the site of the injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back) and PULMONARY PAIN (pain in lung when breathing) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included NORETHINDRONE ACETATE, MULTI VITAMINS & MINERALS and PRO BIOTIC BLEND for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Inflammation, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Inflammation, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Inflammation, at an unspecified dose and frequency. At the time of the report, PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: elevated (High) Test for blood clot was elevated. On an unknown date, Computerised tomogram: inflammation (abnormal) Inflammation all over the body.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On an unknown date, prior to mRNA-1273, antibody test was positive.   This case was linked to US-MODERNATX, INC.-MOD-2021-085271 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085271:Case for husband
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary pain, Vaccination site pain
Clinical narrative: tingling in her throat; "funny sensation" in throat; woozy; pain in back; pain in lung when breathing; pain in lung when breathing; body inflammation on CAT scan; sore arm/body ache; headache; Her arm was also sore at the site of the injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back) and PULMONARY PAIN (pain in lung when breathing) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included NORETHINDRONE ACETATE, MULTI VITAMINS & MINERALS and PRO BIOTIC BLEND for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Inflammation, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Inflammation, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Inflammation, at an unspecified dose and frequency. At the time of the report, PHARYNGEAL PARAESTHESIA (tingling in her throat), OROPHARYNGEAL DISCOMFORT ("funny sensation" in throat), DIZZINESS (woozy), BACK PAIN (pain in back), PULMONARY PAIN (pain in lung when breathing), DYSPNOEA (pain in lung when breathing), INFLAMMATION (body inflammation on CAT scan), MYALGIA (sore arm/body ache), HEADACHE (headache) and VACCINATION SITE PAIN (Her arm was also sore at the site of the injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: elevated (High) Test for blood clot was elevated. On an unknown date, Computerised tomogram: inflammation (abnormal) Inflammation all over the body.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On an unknown date, prior to mRNA-1273, antibody test was positive.   This case was linked to US-MODERNATX, INC.-MOD-2021-085271 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085271:Case for husband
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site swelling, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: throbbing pain; started having pain in the right arm; arm started swelling; sore; swelled around the injection site; hurt from all the way down from shoulder to elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (throbbing pain), PAIN IN EXTREMITY (started having pain in the right arm), PERIPHERAL SWELLING (arm started swelling), PAIN (sore) and INJECTION SITE SWELLING (swelled around the injection site) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (throbbing pain), PAIN IN EXTREMITY (started having pain in the right arm), PERIPHERAL SWELLING (arm started swelling), PAIN (sore), INJECTION SITE SWELLING (swelled around the injection site) and ARTHRALGIA (hurt from all the way down from shoulder to elbow). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PAIN (throbbing pain), PAIN IN EXTREMITY (started having pain in the right arm), PERIPHERAL SWELLING (arm started swelling), PAIN (sore) and INJECTION SITE SWELLING (swelled around the injection site) had not resolved and ARTHRALGIA (hurt from all the way down from shoulder to elbow) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up was received and event outcome was updated to recovered/resolved.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Herpes zoster, Rash erythematous, Rash papular
Clinical narrative: Red rash on left breast like a hatch of 2 square inches; Rash is raised; Rash has white little pustules coming out across it; A little fatigue; Slight headache; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised), RASH PUSTULAR (Rash has white little pustules coming out across it), HERPES ZOSTER (Shingles) and FATIGUE (A little fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sore back. Concomitant products included IBUPROFEN for Sore back.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced FATIGUE (A little fatigue) and HEADACHE (Slight headache). In April 2021, the patient experienced HERPES ZOSTER (Shingles). On 19-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised) and RASH PUSTULAR (Rash has white little pustules coming out across it). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. In May 2021, HERPES ZOSTER (Shingles) had resolved. At the time of the report, RASH ERYTHEMATOUS (Red rash on left breast like a hatch of 2 square inches), RASH PAPULAR (Rash is raised), RASH PUSTULAR (Rash has white little pustules coming out across it), FATIGUE (A little fatigue) and HEADACHE (Slight headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       This case was linked to MOD-2021-176879 (second dose case) (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received contain significant information added new event shingles and updated outcome of all the reported events from unknown to recovered.